12 KBW's Cressida Mawdesley-Thomas looks at the Supreme Court’s recent decision and the likely difficulties it poses to those seeking to bring secondary victim claims in a medical negligence context.
Author: Editor - Christopher Fleming
RLB (in her personal capacity and as executrix of the estate of ALB, deceased) v Dr K: Isaac Hogarth secures £1.75 million settlement for widow and children after young father dies due to undiagnosed bowel cancer
Isaac Hogarth of 12 King’s Bench Walk, instructed by Jasicca Nava of Irwin Mitchell successfully represented the claimant (‘C’) in her claim against Dr King (‘D’). The settlement, reached at a JSM, was approved by HHJ Dunne, sitting as a judge of the High Court on 13 October 2023. The facts In 2013, when ALB … Continue reading RLB (in her personal capacity and as executrix of the estate of ALB, deceased) v Dr K: Isaac Hogarth secures £1.75 million settlement for widow and children after young father dies due to undiagnosed bowel cancer
Material Contribution and Holmes v Poeton Holdings Limited: One Issue Down, More to Go
Henry Charles looks at a recent decision from the Court of Appeal which settles the longstanding question of whether material contribution applies to cases of divisible injury.
CDE v Surrey and Sussex Healthcare NHS Trust; the material contribution elephant in the room
Andrew Roy KC considers the implications of the Court of Appeal’s recent decision CDE v Surrey and Sussex Healthcare NHS Trust [2023] EWCA Civ 1330 in respect of the vexed and important of material contribution.
McCullough and others v Forth Valley Health Board [2023] UKSC 26: Montgomery revisited
John-Paul Swoboda and Chris Fleming consider the Supreme Court’s decision clarifying the correct test to apply when considering what treatment options a doctor is under a duty to discuss with a patient.
Bilal and Malik v St George’s University Hospital NHS Foundation Trust [2023] EWCA Civ 605: informed consent in treatment options.
Christopher Fleming looks at a recent Court of Appeal decision which considered whether the Bolam test has any place in determining what alternative forms of treatment should be discussed with patients.